Come meet aspiring entrepreneurs, inventors, scientists, clinicians, engineers and business professionals. Network with future teammates for our December Pitch Day!
Keynote Renier Brentjens, MD, PhD, Director, Cellular Therapeutics, MSKCC; Scientific Co-Founder of Juno Therapeutics (JUNO).
Featuring three BBI alumni startups:
Frank Borchetta, JD, Founder and CEO, Repairogen.
Kevin O'Rourke, MD, PhD candidate, Co-Founder, York Avenue Diagnostics.
Kate Rochlin, PhD, Founder and CSO, Immunovent.
The Bench to Bedside Initiative (BBI) is supported in part by Weill Cornell Medicine Dean's Entrepreneurship Lab. This event is the beginning of our 12-week seminar series. All attendees are encouraged to form teams and to write business plans around patented technologies invented at Cornell University, Memorial Sloan Kettering Cancer Center and Rockefeller University.
